FGF21 and complication: The present study demonstrates that FGF21 promotes ischaemic angiogenesis and blood perfusion under diabetic conditions and improves the angiogenic capability of EPCs by activating the AMPK/NAD+ pathway, which provides experimental evidence for the potential application of FGF21 in the therapy of diabetic vascular complications.